MEROPENEM AUROBINDO 500 mg Rumeenia - rumeenia - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

meropenem aurobindo 500 mg

apl swift services (malta) limited - malta - meropenemum - pulb. pt. sol. inj./perf. - 500mg - alte antibiotice betalactamice carbapeneme

SILDENAFIL HEMOFARM 25 mg Rumeenia - rumeenia - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

sildenafil hemofarm 25 mg

stada arzneimittel ag - germania - sildenafilum - compr. film. - 25mg - alte preparate urologice (incl. antispastice) medicamente pt. trat. disfunctiei erectile

SILDENAFIL HEMOFARM 50 mg Rumeenia - rumeenia - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

sildenafil hemofarm 50 mg

stada arzneimittel ag - germania - sildenafilum - compr. film. - 50mg - alte preparate urologice (incl. antispastice) medicamente pt. trat. disfunctiei erectile

SILDENAFIL HEMOFARM 100 mg Rumeenia - rumeenia - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

sildenafil hemofarm 100 mg

stada arzneimittel ag - germania - sildenafilum - compr. film. - 100mg - alte preparate urologice (incl. antispastice) medicamente pt. trat. disfunctiei erectile

Recarbrio Euroopa Liit - rumeenia - EMA (European Medicines Agency)

recarbrio

merck sharp & dohme b.v.  - imipenem monohidrat, cilastatin de sodiu, monohidrat relebactam - gram-negativi infectii bacteriene - carbapenems, antibacterials for systemic use, - recarbrio is indicated for:- treatment of hospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap), in adults (see sections 4. 4 și 5. - treatment of bacteraemia that occurs in association with, or is suspected to be associated with hap or vap, in adults. - treatment of infections due to aerobic gram-negative organisms in adults with limited treatment options (see sections 4. 2, 4. 4, și 5. trebuie luate în considerare ghidurile oficiale referitoare la utilizarea adecvată a medicamentelor antibacteriene.

Spherox Euroopa Liit - rumeenia - EMA (European Medicines Agency)

spherox

co.don gmbh - sferoizi ai condrocitelor asociate cu matricea autologă umană - bolile cartilagiului - alte medicamente pentru tulburări ale sistemului musculo-scheletic - repararea cartilajului articular simptomatic defecte ale condilului femural si rotula genunchiului (international cartilaj repair societatea [icrs] gradul iii sau iv) cu defect dimensiuni până la 10 cm2 la adulţi.

Abecma Euroopa Liit - rumeenia - EMA (European Medicines Agency)

abecma

bristol-myers squibb pharma eeig - idecabtagene vicleucel - multiple myeloma; neoplasms; cancer; neoplasms, plasma cell; hemostatic disorders; vascular diseases; cardiovascular diseases; paraproteinemias; blood protein disorders; hematologic diseases; hemic and lymphatic diseases; hemorrhagic disorders; infectious mononucleosis; lymphoproliferative disorders; immunoproliferative disorders; immune system diseases - agenți antineoplazici - abecma is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti cd38 antibody and have demonstrated disease progression on the last therapy.

VIMOVO 500 mg/20 mg Rumeenia - rumeenia - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

vimovo 500 mg/20 mg

astrazeneca ab - suedia - combinatii (naproxen + esomeprazol) - compr. elib. modif. - 500mg/20mg - antiinflamatoare si antireumatice nesteroidiene derivati de acid propionic

Bemfola Euroopa Liit - rumeenia - EMA (European Medicines Agency)

bemfola

gedeon richter plc. - folitropină alfa - anovulația - hormoni sexuali și modulatori ai sistemului genital, - in adult women:anovulation (including polycystic ovarian disease, pcod) in women who have been unresponsive to treatment with clomiphene citrate;stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (art) such as in vitro fertilisation (ivf), gamete intra-fallopian transfer (gift) and zygote intra-fallopian transfer (zift);follitropin alfa in association with a luteinising hormone (lh) preparation is recommended for the stimulation of follicular development in women with severe lh and fsh deficiency. În studiile clinice la acești pacienți au fost definite printr-o concentrație plasmatică de lh endogen < 1. 2 ui / l. in adult men:follitropin alfa is indicated for the stimulation of spermatogenesis in men who have congenital or acquired hypogonadotrophic hypogonadism with concomitant human chorionic gonadotrophin (hcg) therapy.